Table 1.
Clinical Characteristics
| Propofol (n = 10) | Sevoflurane (n = 10) | P value | |
|---|---|---|---|
| Age (yr) | 59 (58–67) | 62 (57–62) | >0.999 |
| Sex (F) | 5 (50) | 4 (40) | 0.659 |
| Height (cm) | 168 (159–172) | 166 (164–171) | 0.873 |
| Weight (kg) | 87 (75–97) | 79 (68–85) | 0.271 |
| Cancer stage | |||
| 1 | 3 (30) | 3 (30) | 0.380 |
| 2 | 1 (10) | 0 | |
| 3 | 6 (60) | 5 (50) | |
| 4 | 0 | 2 (20) | |
| Distal metastases at diagnosis | 0 | 2 (20) | 0.138 |
| Invasion to inferior vena cava | 0 | 1 (10) | 0.325 |
| Redo surgery | 0 | 1 (10) | 0.325 |
| ASA score | |||
| II | 6 (60) | 4 (40) | 0.382 |
| III | 4 (40) | 6 (60) | |
| Surgery type | |||
| Nephrectomy | 7 (70) | 8 (80) | 0.611 |
| Kidney resection | 3 (30) | 2 (20) | |
| Intraoperative characteristics | |||
| Total ropivacaine dose (mg) | 75 (53–75) | 75 (53–120) | 0.633 |
| Lowest mean arterial pressure (mmHg) | 57 (51–67) | 65 (61–67) | 0.082 |
| Blood transfusion | 0 (0) | 1 (10) | 0.317 |
| Crystalloids infusion (ml) | 1500 (1000–1500) | 1500 (1500–2500) | 0.153 |
| Diuresis (ml) | 305 (200–470) | 345 (180–420) | 0.970 |
| Minimal body temperature (oC) | 36.0 (35.7–36.1) | 36.0 (35.5–36.5) | 0.559 |
| Duration of surgery (min) | 60 (50–100) | 90 (60–210) | 0.090 |
| Duration of anesthesia (min) | 132 (100–170) | 125 (105–270) | 0.628 |
| Postoperative characteristics: | |||
| Ventilation time (h) | 1.5 (0–2) | 1 (0–2) | 0.973 |
| PACU stay (days) | 1 (1–1) | 1 (1–1) | 0.470 |
| Hospitalization (days) | 7 (6–7) | 6 (5–7) | 0.262 |
Values are presented as median (Q1–Q3) or number (%). PACU: post anesthetic care unit.